SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett*, Joe Grove*, Oscar A. MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, Diego Cantoni, Sam Scott, Nicola Logan, Shirin Ashraf, Maria Manali, Agnieszka Szemiel, Vanessa Cowton, Elen Vink, William T. Harvey, Chris Davis, Patawee Asamaphan, Katherine Smollett, Lily Tong, Richard OrtonJoseph Hughes, Poppy Holland, Vanessa Silva, David J. Pascall, Kathryn Puxty, Ana da Silva Filipe, Gonzalo Yebra, Sharif Shaaban, Matthew T.G. Holden, Rute Maria Pinto, Rory Gunson, Kate Templeton, Pablo R. Murcia, Arvind H. Patel, Paul Klenerman, Susanna Dunachie, PITCH Consortium, The COVID-19 Genomics UK (COG-UK) Consortium, John Haughney, David L. Robertson, Massimo Palmarini, Surajit Ray, Emma C. Thomson, Darren L. Smith, Gregory R. Young, Matthew Bashton, Clare M. McCann, John H. Henderson, Matthew R. Crown, Wen C. Yew

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences